Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
Duchenne muscular dystrophy (DMD) is a lethal X-linked muscle wasting disorder caused by the absence of dystrophin, a large cytoskeletal muscle protein. Increasing the levels of the dystrophin-related-protein utrophin is a highly promising therapy for DMD and has been shown to improve pathology in d...
Main Authors: | Kennedy, T, Moir, L, Hemming, S, Edwards, B, Squire, S, Davies, K, Guiraud, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2017
|
Similar Items
-
Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
by: Tahnee L. Kennedy, et al.
Published: (2017-10-01) -
Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2/mdx mice
by: Kennedy, T, et al.
Published: (2018) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019) -
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
by: Wakefield, P, et al.
Published: (2000) -
Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
by: Guiraud, S, et al.
Published: (2018)